D.E. Shaw & Co’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-125,020
Closed -$241K 4583
2023
Q2
$241K Buy
125,020
+102,680
+460% +$177K ﹤0.01% 3676
2023
Q1
$18.1K Buy
+22,340
New +$32.6K ﹤0.01% 4158
2022
Q4
Sell
-20,391
Closed -$32K 5239
2022
Q3
$32K Sell
20,391
-71,130
-78% -$162K ﹤0.01% 4750
2022
Q2
$162K Sell
91,521
-49,325
-35% -$125K ﹤0.01% 4614
2022
Q1
$585K Sell
140,846
-112,929
-44% -$379K ﹤0.01% 4278
2021
Q4
$644K Sell
253,775
-181,593
-42% -$598K ﹤0.01% 4254
2021
Q3
$1.71M Buy
435,368
+295,928
+212% +$1.48M ﹤0.01% 3180
2021
Q2
$894K Buy
+139,440
New +$961K ﹤0.01% 3632

Other funds holding GMDA

D.E. Shaw & Co's GMDA Position: Q3 2023 in Review

D.E. Shaw & Co sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q3 2023, closing a stake of 125,020 shares — an estimated $241K sold.

D.E. Shaw & Co first reported a position in GMDA in Q2 2021 and held it in 8 quarters. The position peaked at $1.71M in Q3 2021. 60 funds tracked by Wall St. Rank hold GMDA as of Q3 2023.

  • D.E. Shaw & Co reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 125,020 Gamida Cell Ltd. Ordinary Shares shares in Q3 2023, an estimated $241K.
  • D.E. Shaw & Co first reported a position in Gamida Cell Ltd. Ordinary Shares in Q2 2021 and held it in 8 quarters.
  • D.E. Shaw & Co's Gamida Cell Ltd. Ordinary Shares position peaked at $1.71M in Q3 2021.
  • 60 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q3 2023.

Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.